526 related articles for article (PubMed ID: 33679303)
1. Systematic Review: Quantitative Susceptibility Mapping (QSM) of Brain Iron Profile in Neurodegenerative Diseases.
Ravanfar P; Loi SM; Syeda WT; Van Rheenen TE; Bush AI; Desmond P; Cropley VL; Lane DJR; Opazo CM; Moffat BA; Velakoulis D; Pantelis C
Front Neurosci; 2021; 15():618435. PubMed ID: 33679303
[TBL] [Abstract][Full Text] [Related]
2. The clinical utility of QSM: disease diagnosis, medical management, and surgical planning.
Eskreis-Winkler S; Zhang Y; Zhang J; Liu Z; Dimov A; Gupta A; Wang Y
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27906525
[TBL] [Abstract][Full Text] [Related]
3. Quantifying iron deposition in the cerebellar subtype of multiple system atrophy and spinocerebellar ataxia type 6 by quantitative susceptibility mapping.
Sugiyama A; Sato N; Kimura Y; Fujii H; Maikusa N; Shigemoto Y; Suzuki F; Morimoto E; Koide K; Takahashi Y; Matsuda H; Kuwabara S
J Neurol Sci; 2019 Dec; 407():116525. PubMed ID: 31639532
[TBL] [Abstract][Full Text] [Related]
4. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of QSM over R2* in assessment of parkinson's disease - A systematic review.
Saikiran P;
Neurol India; 2020; 68(2):278-281. PubMed ID: 32415005
[TBL] [Abstract][Full Text] [Related]
6. Quantitative susceptibility mapping reveals alterations of dentate nuclei in common types of degenerative cerebellar ataxias.
Deistung A; Jäschke D; Draganova R; Pfaffenrot V; Hulst T; Steiner KM; Thieme A; Giordano IA; Klockgether T; Tunc S; Münchau A; Minnerop M; Göricke SL; Reichenbach JR; Timmann D
Brain Commun; 2022; 4(1):fcab306. PubMed ID: 35291442
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of abnormal iron distribution in specific regions in the brains of patients with Parkinson's disease using quantitative susceptibility mapping and R2
Cheng Q; Huang J; Liang J; Ma M; Zhao Q; Lei X; Shi C; Luo L
Exp Ther Med; 2020 Jun; 19(6):3778-3786. PubMed ID: 32346442
[TBL] [Abstract][Full Text] [Related]
8. Associations of cortical iron accumulation with cognition and cerebral atrophy in Alzheimer's disease.
Yang A; Du L; Gao W; Liu B; Chen Y; Wang Y; Liu X; Lv K; Zhang W; Xia H; Wu K; Ma G
Quant Imaging Med Surg; 2022 Sep; 12(9):4570-4586. PubMed ID: 36060596
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Susceptibility Mapping in Parkinson's Disease.
Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
[TBL] [Abstract][Full Text] [Related]
11. Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegeneration.
Liddell JR
Neurodegener Dis Manag; 2015 Aug; 5(4):345-64. PubMed ID: 26295717
[TBL] [Abstract][Full Text] [Related]
12. Quantitative susceptibility mapping of basal ganglia iron is associated with cognitive and motor functions that distinguish spinocerebellar ataxia type 6 and type 3.
Marvel CL; Chen L; Joyce MR; Morgan OP; Iannuzzelli KG; LaConte SM; Lisinski JM; Rosenthal LS; Li X
Front Neurosci; 2022; 16():919765. PubMed ID: 36061587
[TBL] [Abstract][Full Text] [Related]
13. Quantitative susceptibility mapping based hybrid feature extraction for diagnosis of Parkinson's disease.
Xiao B; He N; Wang Q; Cheng Z; Jiao Y; Haacke EM; Yan F; Shi F
Neuroimage Clin; 2019; 24():102070. PubMed ID: 31734535
[TBL] [Abstract][Full Text] [Related]
14. Iron Imaging as a Diagnostic Tool for Parkinson's Disease: A Systematic Review and Meta-Analysis.
Pyatigorskaya N; Sanz-Morère CB; Gaurav R; Biondetti E; Valabregue R; Santin M; Yahia-Cherif L; Lehéricy S
Front Neurol; 2020; 11():366. PubMed ID: 32547468
[No Abstract] [Full Text] [Related]
15. Reproducibility of R
Santin MD; Didier M; Valabrègue R; Yahia Cherif L; García-Lorenzo D; Loureiro de Sousa P; Bardinet E; Lehéricy S
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26913373
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging, susceptibility weighted imaging and quantitative susceptibility mapping findings of pantothenate kinase-associated neurodegeneration.
Zeng J; Xing W; Liao W; Wang X
J Clin Neurosci; 2019 Jan; 59():20-28. PubMed ID: 30392836
[TBL] [Abstract][Full Text] [Related]
17. Early differentiation of neurodegenerative diseases using the novel QSM technique: what is the biomarker of each disorder?
Nikparast F; Ganji Z; Zare H
BMC Neurosci; 2022 Jul; 23(1):48. PubMed ID: 35902793
[TBL] [Abstract][Full Text] [Related]
18. Iron quantification in basal ganglia using quantitative susceptibility mapping in a patient with ALS: a case report and literature review.
Ghaderi S; Batouli SAH; Mohammadi S; Fatehi F
Front Neurosci; 2023; 17():1229082. PubMed ID: 37877011
[TBL] [Abstract][Full Text] [Related]
19. Non-Motor Symptom Burdens Are Not Associated with Iron Accumulation in Early Parkinson's Disease: a Quantitative Susceptibility Mapping Study.
Shin C; Lee S; Lee JY; Rhim JH; Park SW
J Korean Med Sci; 2018 Mar; 33(13):e96. PubMed ID: 29573246
[TBL] [Abstract][Full Text] [Related]
20. Quantitative susceptibility mapping (QSM) of the cardiovascular system: challenges and perspectives.
Aimo A; Huang L; Tyler A; Barison A; Martini N; Saccaro LF; Roujol S; Masci PG
J Cardiovasc Magn Reson; 2022 Aug; 24(1):48. PubMed ID: 35978351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
